Potential barriers to rapid testing for human immunodeficiency virus among a commuter population in Johannesburg, South Africa

SOURCE: HIV/AIDS: Research and Palliative Care
OUTPUT TYPE: Journal Article
TITLE AUTHOR(S): N.Tshuma, K.Muloqngo, G.Setswe, L.Chimoyi, B.Sarfo, D.Burger, P.S.Nyasulu
DEPARTMENT: Human and Social Capabilities (HSC)
Print: HSRC Library: shelf number 8435
HANDLE: 20.500.11910/2178

If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at researchoutputs@hsrc.ac.za.


This study aimed to determine barriers to accessing human immunodeficiency virus (HIV) counseling and testing (HCT) services among a commuter population. A cross-sectional, venue-based intercept survey was conducted. Participants were recruited during a 2-day community campaign at the Noord Street taxi rank in Johannesburg, South Africa. Data were collected using a self-administered questionnaire loaded onto an electronic data collection system and analyzed using Stata software. Factors contributing to barriers for HCT were modeled using multivariate logistic regression. A total of 1,146 (567 male and 579 female) individuals were interviewed; of these, 51.4% were females. The majority (59.5%) were aged 25-35 years. Significant factors were age group (15-19 years), marital status (married), educational level (high school), distance to the nearest clinic (.30 km), area of employment/residence (outside inner city), and number of sexual partners (more than one). Participants aged 15-19 years were more likely to report low-risk perception of HIV as a barrier to HCT (odds ratio [OR] 1.62; 95% confidence interval [CI] 1.01-.59), the married were more likely to report low-risk perception of HIV as a barrier to HCT (OR 1.49; 95% CI 1.13-1.96), and those living outside the inner city were more likely to report lack of partner support as a potential barrier (OR 1.94; 95% CI 1.34-2.80), while those with a high school education were more likely to report poor health worker attitude as a potential barrier to HIV testing (OR 2.17; 95% CI 1.36-3.45).